Over 40,000 Oncology professionals have gathered at the ASCO (American Society of Clinical Oncology) in Chicago where we are presenting our Novel Natural Product inhibitor for the PI3K pathway.
See the abstract here
Comments are closed
Our mission on drug discovery and pharma research
